Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT treatment = Holy-grail of oncologists

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Aug 31, 2023 12:15pm

180 Views

Post# 35613996

RE:RE:RE:RE:RE:RE:TLT treatment = Holy-grail of oncologists

Galaxym31 wrote: Seven years of pre clinical work ok .

Theralase is not a big pharma and does not have the resources of a big pharma. I think they have done pretty well considering they have had to go this alone. Getting an actual cancer treatment this close to approval without any help is a real achievement. I think they will be able to do a great deal more once they get adequate funding.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project